In The Lever, National Breast Cancer Coalition (NBCC) President Fran Visco commented on the Food and Drug Administration’s (FDA) drug approval process and the drug industry’s influence on the patient advocacy community.
Many patient organizations are only interested in more drugs, not better drugs. I was in a science meeting and one of the participants from a patient group said, ‘I’m just trying to get more drugs into patients.’ I said that’s not what we’re interested in. We’re interested in drugs that work.
Read the full story on The Lever, and learn more about NBCC’s work on FDA reform.
